Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–17 of 17 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07481786
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bevacizumab, +18 more
- Locations
-
- The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
- Sun yat-sen University Cancer Center Guangzhou, Guangdong, China
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou, Guangdong, China
Recruiting
QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT
NCT07327788
- Conditions
- Bevacizumab, Hepatecellular Carcinoma, Iparomlimab and Tuvonralimab Injection, +3 more
- Locations
-
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
NCT06323382
- Conditions
- Advanced Hepatocellular Carcinoma, Anti-PD1/PDL1 Antibody, Bevacizumab
- Locations
-
- Chinese PLA hospital Beijing, Beijing Municipality, China
NCT07085169
- Conditions
- Bevacizumab, Colo-rectal Cancer, Colonic Diseases, +12 more
- Locations
-
- SanMing First Hospital Sanming, China
- Ruijin Hospital Shanghai, China
NCT06755684
- Conditions
- Antineoplastic Agents, Bevacizumab, Bronchial Neoplasms, +15 more
- Locations
-
- Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China
NCT06609863
- Conditions
- Adenocarcinoma, Advanced Hepatocellular Carcinoma, Atezolizumab, +12 more
- Locations
-
- Chinese PLA General hospital Beijing, None Selected, China
NCT05970666
- Conditions
- Adebrelimab, Adenocarcinoma, Bevacizumab, +13 more
- Locations
-
- The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
NCT05970302
- Conditions
- Bevacizumab, Capecitabine, Colonic Diseases, +16 more
- Locations
-
- Lin Yang Beijing, China
Enrolling by Invitation
Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic Telangiectasia Within the French Hereditary Hemorrhagic Telangiectasia Network
NCT07445347
- Conditions
- Bevacizumab, Cardiovascular Abnormalities, Cardiovascular Diseases, +16 more
- Locations
-
- Centre hospitalier universitaire de Poitiers Poitiers, France
NCT07543783
- Conditions
- Adebrelimab (SHR-1316), Adenocarcinoma, Bevacizumab, +11 more
- Locations
-
Not specified
NCT07004335
- Conditions
- Advanced Melanoma, Bevacizumab, CTLA-4, +4 more
- Locations
-
- The Fourth Hospital of Hebei Medical University Shijiazhuang, China
Not Yet Recruiting
Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer
NCT06539559
- Conditions
- Bevacizumab, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Beijing Chaoyang District San Huan Cancer Hospital Beijing, Beijing Municipality, China
- Cancer Hospital of HuanXing ChaoYang District Beijing, Beijing Municipality, China
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
NCT05263947
- Conditions
- Bevacizumab, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
NCT01951482
- Conditions
- Bevacizumab, Brain Diseases, Brain Metastases, +8 more
- Locations
-
- Sun Yat-sen University of Cancer Center Guangzhou, Guangdong, China
NCT05807893
- Conditions
- Bevacizumab, Brain Diseases, Brain Metastases, +17 more
- Locations
-
- Likun Chen Guangzhou, Guangdong, China
NCT01810744
- Conditions
- Astrocytoma, Bevacizumab, Capillaroscopy, +20 more
- Locations
-
- Centre Georges François Leclerc Dijon, France
NCT01311960
- Conditions
- Anti-VEGF, Bevacizumab, Conjunctival Diseases, +3 more
- Locations
-
- Faculty of medicine, Chulalongkorn university Pathumwan, Bangkok, Thailand